ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 239 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $959,000 | -31.5% | 23,737 | -2.5% | 0.00% | -50.0% |
| Q2 2015 | $1,400,000 | -8.3% | 24,335 | +1.5% | 0.00% | 0.0% |
| Q1 2015 | $1,527,000 | +10.7% | 23,983 | +7.3% | 0.00% | +100.0% |
| Q4 2014 | $1,380,000 | +47.9% | 22,357 | -7.0% | 0.00% | 0.0% |
| Q3 2014 | $933,000 | 0.0% | 24,044 | -11.2% | 0.00% | 0.0% |
| Q2 2014 | $933,000 | -29.7% | 27,088 | -11.8% | 0.00% | 0.0% |
| Q1 2014 | $1,328,000 | +15.1% | 30,724 | +6.1% | 0.00% | 0.0% |
| Q4 2013 | $1,154,000 | -13.9% | 28,957 | -40.8% | 0.00% | 0.0% |
| Q3 2013 | $1,340,000 | +50.1% | 48,921 | +47.3% | 0.00% | 0.0% |
| Q2 2013 | $893,000 | – | 33,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |